CADM is an idiopathic autoimmune disorder associated with various autoantibodies, one of the most specific being anti-melanoma differentiation-associated gene 5 (anti-MDA5) antibodies. This evidence concerns the gene IFIH1 and clinically amyopathic dermatomyositis.